GlassScriptPhysician profile
William C Stoll
NPI 1811926900
$396.53
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $113 · 2021: $103.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $57.21 | 2019-2020 | |
| Smith+Nephew, INC. | $48.44 | 2020 | |
| Melinta Therapeutics, LLC | $39.83 | 2019 | |
| Bioventus LLC | $36.87 | 2019-2021 | |
| Organogenesis INC. | $31.83 | 2021 | |
| Crossroads Extremity Systems, LLC | $25.04 | 2019 | |
| Osteomed LLC | $23.96 | 2020 | |
| Osiris Therapeutics INC. | $23.30 | 2019 | |
| Zimmer Biomet Holdings, INC. | $21.35 | 2021 | |
| Kerecis Limited | $20.63 | 2019 | |
| Integra Lifesciences Corporation | $18.11 | 2020 | |
| Abbott Laboratories | $16.07 | 2021 | |
| Stryker Corporation | $13.33 | 2021 | |
| Orthofix Medical, INC. | $12.90 | 2019 | |
| Paragon 28, INC. | $7.66 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.